Oral Perphenazine 8 mg: A Low-Cost, Efficacious Antiemetic Option
- PMID: 33449568
- PMCID: PMC7785708
- DOI: 10.1213/ANE.0000000000005279
Oral Perphenazine 8 mg: A Low-Cost, Efficacious Antiemetic Option
Conflict of interest statement
Conflicts of Interest: K. Subramaniam worked as a consultant for Octapharma in February 2020, and also receives annual royalties for textbooks from Springer. J. P. Williams is on the Board of Directors for the Allegheny County Medical Society, and for the Pennsylvania Medical Society. He is also on the Council for Medical Education for the American Medical Association. He is also on the Board and an investor for a medical marijuana dispensary.
Comment in
-
In Response.Anesth Analg. 2021 Feb 1;132(2):e31-e33. doi: 10.1213/ANE.0000000000005280. Anesth Analg. 2021. PMID: 33449569 No abstract available.
Comment on
-
Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting.Anesth Analg. 2020 Aug;131(2):411-448. doi: 10.1213/ANE.0000000000004833. Anesth Analg. 2020. PMID: 32467512 Review.
References
-
- Gan TJ, Belani KG, Bergese S, et al. Fourth consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2020;131:411–448. - PubMed
-
- Williams BA, Kentor ML, Skledar SJ, Orebaugh SL, Vallejo MC. Routine multimodal antiemesis including low-dose perphenazine in an ambulatory surgery unit of a university hospital: a 10-year history. Supplement to: Eliminating postoperative nausea and vomiting in outpatient surgery with multimodal strategies including low doses of nonsedating, off-patent antiemetics: Is “zero tolerance” achievable? ScientificWorldJournal. 2007;7:978–986. - PMC - PubMed
-
- Geist ET, Gross BD. Reduction of ketamine-induced emergence phenomena by preoperative promethazine. J Oral Maxillofac Surg. 1982;40:549–550. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources